Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nucleic acid-binding properties of the RRM-containing protein RDM1.

Samia Hamimes1, Dominique Bourgeon, Alicja Z Stasiak

  • 1International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, 69372 Lyon, France.

Biochemical and Biophysical Research Communications
|April 25, 2006
PubMed
Summary

The RDM1 protein binds DNA and RNA, with activity influenced by pH. A mutation in its RD motif alters how RDM1 interacts with single-stranded DNA, impacting cellular responses to cancer drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin impacts the differentiation of mouse bone marrow cells into macrophages affecting tumour immunity.

Heliyon·2024
Same author

Theta-curves in proteins.

Protein science : a publication of the Protein Society·2024
Same author

DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks.

Nucleic acids research·2023
Same author

AlphaFold Blindness to Topological Barriers Affects Its Ability to Correctly Predict Proteins' Topology.

Molecules (Basel, Switzerland)·2023
Same author

Impact of IDH Mutations, the 1p/19q Co-Deletion and the G-CIMP Status on Alternative Splicing in Diffuse Gliomas.

International journal of molecular sciences·2023
Same author

Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas.

Cancers·2021

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cellular Biology

Background:

  • RDM1 (RAD52 Motif 1) is a vertebrate protein crucial for cellular responses to cisplatin, an anti-cancer drug.
  • RDM1 features an RNA recognition motif and an RD motif, shared with the RAD52 DNA repair protein.
  • RDM1 exhibits in vitro binding to both single- and double-stranded DNA, recognizing cisplatin-induced DNA distortions.

Purpose of the Study:

  • To conduct an in-depth analysis of RDM1's nucleic acid-binding properties.
  • To investigate the influence of pH on RDM1's DNA-binding activity.
  • To explore the role of the RD motif in RDM1's nucleic acid interactions.

Main Methods:

  • Gel-shift assays were employed to study RDM1-nucleic acid interactions.
  • Electron microscopy provided structural insights into RDM1 binding.

Related Experiment Videos

  • Competition gel-shift experiments assessed nucleic acid discrimination.
  • Site-directed mutagenesis generated an RDM1 variant (L119GF --> AAA) in the RD motif.

    • Main Results:

    • RDM1 displays acidic pH-dependent DNA-binding activity.
    • RDM1 binds to both RNA and DNA.
    • Evidence suggests RDM1 can discriminate between RNA and DNA.
    • The L119GF --> AAA mutation in the RD motif impacts RDM1's binding to single-stranded DNA.

    Conclusions:

    • RDM1's nucleic acid-binding properties are complex and pH-sensitive.
    • The RD motif is critical for RDM1's interaction with single-stranded DNA.
    • Understanding RDM1's binding mechanisms may inform cancer therapy strategies involving cisplatin.